BioInvent International AB (publ) (LON:0H22)
London flag London · Delayed Price · Currency is GBP · Price in SEK
29.73
+0.13 (0.42%)
At close: Sep 12, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Pharmaceutical
44.69M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
-37.47%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
United States
36.82M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-22.30%
Log In
Log In
Log In
Log In
Upgrade
Sweden
3.89M
Log In
Log In
Log In
Log In
Upgrade
Sweden Growth
-78.72%
Log In
Log In
Log In
Log In
Upgrade
Europe
2.93M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-0.85%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
1.05M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
-63.17%
Log In
Log In
Log In
Log In
Upgrade
Japan
-
Log In
Log In
Log In
Log In
Upgrade